Matinas Biopharma Holdings, Inc. Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 08/05/2026 | Sep 2025Filed 10/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 08/05/2026 | Sep 2024Filed 10/11/2025 | Jun 2024Filed 14/08/2025 | Mar 2024Filed 15/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$1.3 | −$1.9 | −$1.5 | −$5.2 | −$1.7 | −$4.3 | −$5.7 | −$5.8 | |
| −$0.21 | −$0.30 | −$0.40 | −$1.03 | −$0.33 | −$0.85 | −$1.15 | −$1.34 | |
| 6.4 | 6.4 | 5.4 | 5.1 | 5.1 | 5 | — | — |
Trend